Cancer - Testicular
Testicular cancer is a type of cancer that develops in the testicles, a part of the male reproductive system. In the United States, about 8,000 to 9,000 diagnoses of testicular cancer are made each year. Over his lifetime, a man's chance of getting testicular cancer is roughly 1 in 250. It is most common among males aged 15-40 years. Testicular cancer has one of the highest cure rates of all cancers: in excess of 90%; essentially 100% if it has not spread. Even for the relatively few cases in which the cancer has spread widely, chemotherapy offers a cure rate of at least 50%.
Because testicular cancer is curable (stage I can have a success rate of >95%) when detected early, experts recommend regular monthly testicular self-examination after a hot shower or bath, when the scrotum is looser. Men should examine each testicle, feeling for pea-shaped lumps.
A man with one remaining testis can lead a normal life, because the remaining testis takes up the burden of testerone production and will generally have adequate fertility. However, it is worth the expense of measuring hormone levels before removal of a testicle, and sperm banking may be appropriate for younger men who still plan to have children, since fertility may be lessened by removal of one testicle, and can be severely affected if extensive chemotherapy and/or radiotherapy is done.
Less than five percent of those who have testicular cancer will have it again in the remaining testis. A man who loses both testicles will normally have to take hormone supplements, and will be infertile, but can lead an otherwise normal life.
...More at Wikipedia
Related Links:
Cancer - Testicular
Questions recently asked by other users
Latest Cancer / Oncology News From Medical News Today.
- Bovie Medical Corporation Announces FDA 510(K) Clearance To Market SEER Tissue Resection Device
- Randomized Phase 2 Study Of IMC-A12 For HER2-Expressing Advanced Breast Cancer Commences Patient Enrollment
- GenVec Announces Interim Survival Data In Pivotal Trial Of TNFerade™ In Locally Advanced Pancreatic Cancer
- Relapsed Ovarian Cancer - Submitted New Drug Application To FDA For Trabectedin
- Higher Risk Of Certain Cancers Being Recorded In HIV-Positive People
- Ovarian Cancer Cells Destroyed By New Platinum-Phosphate Compounds
- Gentium Provides An Update On The Phase 3 Treatment Trial Of Defibrotide For Severe Veno-Occlusive Disease
- Lymphoma Association Launches New Short Film
- New Imaging Technique Tracks Cancer-Killing Cells Over Prolonged Period In First-Ever Stanford Case Study
- Survival Of Head And Neck Cancer Patients Is Greatly Affected By Coexisting Ailments
- Common Virus Helps Quality Of Life For Sarcoma Patients Says Cancer Expert
